anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
Hypoxia is one of the major environmental problems limiting the healthy development of intensive aquaculture. Marine benthic shellfish are encountering heightened problems related to hypoxic stress as a result of ongoing human activities and aquaculture operations. Razor clam Sinonovacula constricta, a commercially valuable shellfish, has not yet been reported in studies on physiological changes caused by hypoxia and reoxygenation. To understand the negative effects of hypoxia and reoxygenation on the clams, we set up two low-oxygen concentration groups (DO 2.0 mg/L and DO 0.5 mg/L) and assessed multiple aspects of oxidative damage to their hepatopancreas and gills. After the hypoxic stress, the two tissues of the razor clam suffered varying degrees of damage, including cell degeneration and disruption of mitochondrial cristae. After reoxygenation, the 2.0 mg/L group recovered substantially, but the clams in the 0.5 mg/L group still unrecovered. The activities of antioxidant enzymes (MDA, T-AOC, SOD, GPX, and CAT) in clams were considerably altered by acute hypoxia and reoxygenation. Briefly, there was a growing and then declining trend in MDA, T-AOC, and SOD activities in the hepatopancreas, whereas GPX and CAT activities showed the converse trend. In the hepatopancreas and gills, the level of anti-apoptotic gene Bcl-2 transcripts gradually decreased with the duration of hypoxia and increased following reoxygenation. However, changes in the transcript level of the pro-apoptotic gene Bax were in contrast to that of Bcl-2. The TUNEL assay revealed that hypoxia caused apoptosis. Furthermore, at DO 0.5 mg/L, the degree of apoptosis was more significant than at DO 2.0 mg/L, and hepatopancreatic apoptosis was more severe than gill apoptosis. Collectively, our findings imply that hypoxia induces oxidative stress, histological damage, and apoptosis in razor clams in a concentration-dependent and tissue-specific manner. These consequences serve as a reminder that prolonged recovery periods may be required for razor clams to fully recover from oxidative damage resulting from hypoxia-reoxygenation episodes.
Patients who are not able to successfully increase their potassium intake at 4 weeks with dietary counselling will receive potassium citrate supplements. They will receive oral potassium supplementation in the form of 50 to 100 mmol of potassium citrate (as 25 to 50 ml of the liquid solution).
An interactive home treatment system and method is disclosed. Patient data is collected via a handheld device and stored in a database. The data may be related to self-treatments, symptoms, or patient behavior. The data are analyzed with an analytic tool and the analysis is used to generate a message that is transmitted to a treating health care professional or to the patient, or both. A set of predetermined rules may be applied to the data. The rules may be modified by the treating health care professional, the patient, or both. The handheld device, the database, and the analytic tool may be web-enabled to facilitate communication from virtually anywhere.
Esophageal squamous cell carcinoma (ESCC) is one of the gastrointestinal malignancies with high prevalence and poor prognosis. Previous reports suggested that circular ribose nucleic acids might exert regulatory functions in ESCC. This study aims to explore the role of circ_0000592 in ESCC progression, providing novel insights into the diagnosis and therapeutic avenues for ESCC. The GSE131969 data set was utilized to assess circ_0000592 expression in ESCC. The validation was performed in the tumorous tissues of ESCC patients (n = 80) and human-immortalized ESCC cell lines. The correlation between circ_0000592 expression and prognosis was analyzed. The impact of circ_0000592 on ESCC cell activity was evaluated through downregulating circ_0000592, as well as encompassing cell viability, migration, and invasion abilities. The downstream pathway of circ_0000592 was explored by binding site prediction from the TargetScan database, followed by in vitro and in vivo experiments. An in vivo xenograft tumor model was established to highlight the role of circ_0000592 in ESCC. Patients with ESCC exhibited higher circ_0000592 expression levels compared to noncancerous patients, which were associated with reduced survival time, higher TNM stage, and increased lymph node metastasis. The circ_0000592 downregulation suppressed cell viability, migration, and invasion abilities in vitro. Mechanistically, circ_0000592 countered the inhibitory effects on the target gene Frizzled 5 (FZD5) through interactions with miR-155-5p. The overexpression of miR-155-5p curtailed the luciferase activity of circ_0000592 in ESCC cells, inhibiting downstream molecule FZD5 protein expression and subsequently mitigating the detrimental consequences of escalated circ_0000592 expression in ESCC cells. Consistently, circ_0000592 downregulation curbed proliferation and metastasis of ESCC tumors in vivo. In summary, circ_0000592 promoted the progress of ESCC by counteracting the inhibitory impact on FZD5 through its interaction with miR-155-5p. Together, our findings highlighted circ_0000592 as a prospective therapeutic target for ESCC.
PURPOSE:To make it possible to carry out extremely early diagnosis of hepatic disorder, by adding blood, etc. of a test individual to a culture medium, cultivating hepatic parenchymal cells in the above-mentioned culture medium, and judging the presence or absence of division and growth thereof. CONSTITUTION:Blood, blood plasma or blood serum of a test individual, e.g. a warm-blooded animal, is added to a culture medium, and hepatic parenchymal cells of the warm-blooded animal are then inoculated into the above-mentioned culture medium and cultivated preferably at 35-39 deg.C for one day - 2 weeks to judge the division and growth of the hepatic parenchymal cells in the culture medium. EFFECT:If there is damage to the liver, the division and growth of the hepatic parenchymal cells are observed in the culture medium due to the release of the hepatic cell growth factor to the blood. USE:In addition to the diagnosis of hepatic disorder, safety tests of chemicals, etc. can be carried out by using animals.
IPCI: CDDP (30-60 mg) with 5FU (500-600 mg/sqm of body surface), both dissolved in 100 mL of normal saline, after abdominal paracentesis and catheterization with following closed drainage of the ascites up to small amount of remaining liquid. After IPCI, the catheter occluded. Administered biweekly during four weeks of the course, totally two times.
This will be a randomized control, web-based trial for weight management with four treatment arms. Participants will be assigned to receive tailored materials from either: 1) the Balance program, 2) the Balance and Nourish programs, 3) the Balance and Achieve programs, or 4) the Balance, Nourish and Achieve programs. Participants will be recruited directly through their health care organization. In order to participate, participants must visit the website to confirm their eligibility, e.g. valid e-mail address. Those who wish to participate will provide consent on the Web, and then will be presented with an online questionnaire. These questions will provide baseline data for each participant and will be the basis for the tailoring of the Balance materials each participant will receive. Within 24 hours of submitting the completed questionnaire, participants will be informed by e-mail that their tailored Balance plan is available on the website. They will receive follow-up materials by e-mail during the six-week period after they enroll. Participants who have been assigned to additional programs will be sent e-mails with links to the relevant programs. At 3, 12 and 18 months, all participants will be assessed via an online survey. The assessment will include weight management parameters, psychosocial outcomes, and program utilization. This data will be self-reported.

STUDY POPULATION The study sample will be drawn from members of three integrated delivery systems: Kaiser Permanente Colorado (KPCO), Kaiser Permanente Ohio (KPOH), and Group Health Cooperative (GHC) of Puget Sound. In order to participate, participants must access and enroll in the study on the Web. A total of 1,848 participants will be enrolled within a six-month period, with approximately 450 participants in each treatment arm. By 18-month follow-up, we assume successful data collection from at least 65 percent of the enrollees, or 1200 participants, 300 in each treatment group. The study is open to those who meet the inclusion and exclusion criteria.
PURPOSE: To assess the available evidence to support a genetic contribution and define the role of common and rare variants in tinnitus.
METHODS: After a systematic search and quality assessment, 31 records including 383,063 patients were selected (14 epidemiological studies and 17 genetic association studies). General information on the sample size, age, sex, tinnitus prevalence, severe tinnitus distribution, and sensorineural hearing loss was retrieved. Studies that did not include data on hearing assessment were excluded. Relative frequencies were used for qualitative variables to compare different studies and to obtain average values. Genetic variants and genes were listed and clustered according to their potential role in tinnitus development.
RESULTS: The average prevalence of tinnitus estimated from population-based studies was 26.3% for any tinnitus, and 20% of patients with tinnitus reported it as an annoying symptom. One study has reported population-specific differences in the prevalence of tinnitus, the white ancestry being the population with a higher prevalence. Genome-wide association studies have identified and replicated two common variants in the Chinese population (rs2846071; rs4149577) in the intron of TNFRSF1A, associated with noise-induced tinnitus. Moreover, gene burden analyses in sequencing data from Spanish and Swede patients with severe tinnitus have identified and replicated ANK2, AKAP9, and TSC2 genes.
CONCLUSIONS: The genetic contribution to tinnitus is starting to be revealed and it shows population-specific effects in European and Asian populations. The common allelic variants associated with tinnitus that showed replication are associated with noise-induced tinnitus. Although severe tinnitus has been associated with rare variants with large effect, their role on hearing or hyperacusis has not been established.
This group will include 30 burned patients who will receive resistance exercises 8 weeks (3times/week) by using dumbbells and sand bags in addition to their physical therapy program (splinting, stretching ex. and ROM ex.) and medical treatment (medications as cataflam, alphintern, zinetac and hemacaps and wound dressings).
The most commonly used therapy for lumbar disc herniation (LDH) are partial discectomy or discectomy with fusion if there was an additional mechanical disorder in the underlying functional spinal unit. However, the problems associated with discectomy are intervertebral disc height loss and the segmental instability, thought to be a risk for failed back surgery syndrome or recurrence lumbar disc herniation. Fusion has also been criticised for its side effects of adjacent segment degeneration(ASD), pseudarthrosis and bone-graft morbidity. To prevent such complications , a new family of dynamic implants have been established. Wallis interspinous implant (Abbott Laboratories, Bordeaux, France) , invented by J. Senegas, is one of them. It consisted of a interspinous blocker made out of polyetheretherketone (PEEK) to limit extension and two dacron tapes around the spinous processes in order to secure the implant and limit flexion. The aim of using this device is to unload the facet joints, to restore foraminal height and to provide sufficient stability especially in extension but still allow motion in the treated segment. Previous clinical trials and biomechanical studies are promising, however, the superiority of a discectomy with Wallis in comparison to a discectomy alone for primary lumbar disc herniation has yet to be determined. The purpose of this prospective controlled study was to evaluate the clinical effect of lumbar discectomy combined with Wallis interspinous device, comparing with posterior lumbar discectomy alone. Our hypothesis was that the use of the Wallis device would have better clinical and radiological outcomes than lumbar discectomy alone.
Participants with baseline weight of 15 to \<20 kg received 150 mg of atazanavir plus 100 mg of ritonavir once daily with an optimized background therapy of 2 nucleoside reverse transcriptase inhibitors (NRTIs) for 24 weeks. In countries without locally approved pediatric indication for atazanavir, patients may continue to receive study treatment, with regular 12-week visits, until the age of 18 years.
This observational, pragmatic PK study will enroll lactating women who are taking medications that were prescribed by their treating medical provider or as an over-the-counter medication. Study investigators will not be prescribing or recommending medication use as part of this study. Feasibility of the study is enhanced by a partnership with The Milk Bank, which will refer women identified as taking medications to study investigators. Subjects will also be recruited from Eskenazi Health and IU Health. Blood and breast milk samples will be collected from lactating women prior to administration of a dose of drug and at varying time points after dosing to characterize maternal and infant plasma PK and transfer of drug into breast milk.

Another phase of the study will evaluate plasma concentrations of DOIs in breastfed infants whose mothers are already taking the medications. Infant blood samples will be obtained by heel stick or venipuncture from enrolled infants in order to determine the concentration of the drug in the infant's blood. The design of this study allows for the evaluation of the use of drugs in lactating women with minimal risk to participants. As blood draws and expressed milk samples are obtained often during clinical care or daily postpartum life, this study is not greater than minimal risk. Lactating women taking a DOI will have biospecimens collected from maternal breast milk and maternal blood. Breast milk will be collected from pumped or manually expressed samples.
The present invention discloses a multi-functional medical diagnosis system, which mainly integrates computer apparatuses of medical facilities and smart phones or portable computers of patients into a multi-functional medical diagnosis system provided with identity confirmation and emergency contact person image mutual transmission, convenience of portability, diagnosis process video recording, after-diagnosis notes for reminding patients, next appointment time and message transmission. A computer host and a monitor are installed in an appropriate location in a consulting room. The computer is connected to an image capturing device capable of recording a diagnosis process. Further, the computer is installed with a data transmission device. The data transmission device can transmit medical record data and image data, and can transmit the medical record data by associating with a multi-functional diagnosis system program built in a patient's smart phone or portable computer, so as to achieve the object of providing portable medical record data and audiovisual contents of diagnosis process for the patient. Meanwhile, in case of emergency, the invention can immediately contact the patient's emergency contact person, and explain the patient's condition via image mutual transmission to further decide a treatment. During the process, mutual or multi-party conference audiovisual contents are all recorded automatically to reach emergency treatment decision. Further, the patient can also keep the medical record data, and record time for next appointment. Moreover, the invention facilitates the diagnosis process when the patient changes a medical facility abroad by providing medical record histories. And the invention can also avoid medical disputes. Accordingly, the invention provides multiple functions.
Sleep quality is among the common complication in patients on dialysis and serious affect their health and quality of life; however, other associated risk factors are unclear. This study aimed to investigate the risk factors affecting sleep quality in patients on dialysis. Data were collected from 260 patients who met the inclusion criteria at out hospital from May 2023 to October 2023. Questionnaires were completed by patients, and biochemical indicators were obtained from past medical records. Univariate and multifactor analyses were used to find factors influencing sleep quality in patients on dialysis. Simple linear regression results showed that female, type of kidney primary disease, high systolic blood pressure (SBP), pruritus, pruritus frequency, restless legs syndrome (RLS), anxiety, and depression were associated with poor sleep quality. Blood biochemical parameters showed that low sodium and calcium levels and high ferritin levels were associated with poor sleep quality. Multiple linear regression statistics showed that female, pruritus, RLS, high SBP, depression, and high ferritin levels were associated with poor sleep quality. This study showed that female, chronic nephritis syndrome, high SBP, pruritus, RLS, low mood. and high ferritin levels were associated with poor sleep quality. Future development of individual nursing and targeted therapies is key to improving sleep quality in patients on dialysis.
An eye mask with eye relief and cleaning effects which includes a pair of cover bodies. Each cover body comprises a base layer, a nutrient layer and an outer layer. The base layer is impregnated with a nutrient fluid. The nutrient layer is laid on the base layer by ultrasonic welding technologies and a plurality of meshes is distributed thereon for being attached to the eyes of an user. The nutrient fluid of the base layer can penetrate into the nutrient layer and ooze out from the meshes. The outer layer is disposed on the other side of the base layer opposite to the nutrient layer and a hollow portion is formed between the base layer and the outer layer. The hollow portion is externally exposed. A connecting portion is disposed between the pair of cover bodies to connect the pair of cover bodies. The connecting portion includes a plurality of nodal points so that the connecting portion can be torn apart by an external force, thereby separating the pair of cover bodies. The hollow portion allows fingers to be placed in and further utilizes the nutrient layer to clean and maintain the facial skin.
During their preadmission testing, patients planning to undergo sleeve gastrectomy bariatric surgeries will be consented (by having them sign consent forms) and recruited for the study. A trained individual will track these patients after the surgery in the post anesthesia care unit until discharge and assess their length of stay and possible nausea / vomiting. The exact time the investigators are looking to assess is patient arrival to the post anesthesia care unit until patient ready for discharge when the anesthesiologist writes the anesthesia evaluation. The time the reversal agent is administered during the start of skin closure until patient medically ready to leave the post anesthesia care unit will also be taken into account. Blinded to the treatment group, the trained individual will ask each patient every 15 minutes after arrival to the post anesthesia care unit if they are experiencing nausea or vomiting. As an exploratory measure, the trained individual will assess the patient at these same times (every 15 minutes) and determine their oxygen saturation. The investigators will take all the data from the observations and use statistical means to measure what is significant. A discussion and conclusion will follow. Finally, the principal investigator will submit the study outcomes to an anesthesia journal.
Gastrointestinal disorders dysregulate the biochemical environment of the gastrointestinal tract by altering pH conditions during the gastric phase of digestion or by reducing the secretion of pancreatin during the intestinal part of the process. Ingested functional food could therefore lose some of its health-promoting potential apart from its nutritional value. In this work, we aimed to manufacture bread marked by decreased gluten content, using a commercial or laboratory sourdough, that could be appropriate for patients afflicted with wheat allergy, hypertension and pancreatic malfunctions. A reference sample (no sourdough) was prepared alongside wheat and wheat-rye bread samples-produced with either commercial or laboratory sourdough (L. plantarum BS, L. brevis 1269, L. sanfranciscensis 20663). We measured the QQQPP allergen content (ELISA) in bread extracts digested in vitro and determined how these extracted components affect the level of active angiotensin and alpha amylase (spectrophotometry). We then elucidated how these properties changed when physiological digestion conditions (pH and pancreatin activity) were disturbed to mimic gastric hyperacidity, hypochlorhydria or exocrine pancreatic insufficiency. The key finding was that every tested type of bread produced with laboratory sourdough exhibited pronounced angiotensin-converting enzyme inhibition. The effect was preserved even in dysregulated digestive conditions. The use of laboratory sourdough prevented an increase in allergenicity when pancreatin was restricted as opposed to the commercial sourdough, which surpassed the reference sample reading at 50% pancreatin. No statistically consistent link was reported when the inhibition of alpha amylase was assayed. In conclusion, functional bread manufactured with sourdough composed of L. plantarum BS, L. brevis 1269, and L. sanfranciscensis 20663 was shown to be potentially capable of contributing to the treatment against hypertension as evidenced by in vitro research. It was also moderately safer with regard to its allergenicity.
The present invention relates to a composition for anti-oxidation, anti-inflammation, anti-diabetes, skin-whitening, wrinkle improvement, or gout inhibition comprising an extract of Pyrrosia lingua. The extract of Pyrrosia lingua according to the present invention inhibits DPPH radicals, ABTS radicals, and TBARs and increases PFs to exhibit an antioxidant effect, and inhibits hyaluronidase to exhibit an anti-inflammatory effect. In addition, the extract of Pyrrosia lingua inhibits tyrosinase to exhibit a skin-whitening effect and inhibits elastase or collagenase to exhibit a wrinkle improvement effect. Also, the extract of Pyrrosia lingua inhibits α-amylase or α-glucosidase to exhibit an anti-diabetes effect and inhibits xanthine oxidase to exhibit a gout (arthritis) suppressing effect. Therefore, the extract of Pyrrosia lingua can be expected to be usefully used for a pharmaceutical composition, a food composition, a cosmetic composition, etc. having the above-mentioned physiological activity.
Oral mucositis, also known as stomatitis, is the most common complication of cancer treatment. Mucositis affects the patient's nutrition, daily functions, and quality of life, may compromise the ability to tolerate scheduled therapy. For this reason, the children to be included in the study will be randomly divided into three groups. Sodium bicarbonate, which is the routine care in the clinic, will be administered to the control group, and to the intervention groups, saline in addition to the routine care and black mulberry syrup will be applied in addition to the routine care. Data will be collected according to Patient Information Form, International Child Mucositis Assessment Scale (ChIMES), World Health Organization Mucositis Classification and neutrophil counts. Oral care will be applied to the groups 4 times a day for 14 days. The International Child Mucositis Rating Scale (ChIMES), World Health Organization Mucositis Classification and neutrophil counts will be evaluated by the researchers on the 1st, 2nd, 4th, 8th and 16th days.